Updates in Myelofibrosis
Top Stories
Early, Encouraging Data for Glioblastoma Treatment Reported at ASCO

All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham have exceeded both their median and expected progression-

Medical Xpress
2w ago
'Unprecedented' 100% of First 14 Untreated Patients With Rectal Cancer Respond to PD-1 Blocker Dostarlimab-gxly

In a study of patients with locally advanced mismatch repair–deficient (dMMR) rectal cancer, 6 months of treatment with the anti–PD-1 agent dostarlimab-gxly alone led to clinical complete responses

The ASCO Post
3w ago
Momelotinib Bests Danazol in Symptomatic, Anemic Myelofibrosis

Momelotinib proved superior to danazol for key outcomes in a phase 3 trial of patients with symptomatic and anemic myelofibrosis.

Cancer Therapy Advisor
1w ago